Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion type Assertion NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_head.
- NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_provenance.
- NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion evidence source_evidence_literature NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_provenance.
- NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion SIO_000772 19931309 NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_provenance.
- NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion wasDerivedFrom befree-20140225 NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_provenance.
- NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion wasGeneratedBy ECO_0000203 NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_provenance.